Background Recent reports have raised concerns that postnatal steroids may cause neuro-
developmental impairment in preterm infants. This systematic review was performed with the …

Background Bronchopulmonary dysplasia (BPD), defined as oxygen dependence at 36
weeks postmenstrual age (PMA), remains an important complication of prematurity …

Background Corticosteroids have been used late in the neonatal period to treat chronic lung
disease (CLD) in preterm babies, and early to try to prevent it. CLD is likely to be the result of …

Aim: To compare short‐term effects and neurodevelopmental outcome of neonatal
glucocorticoid therapy between two centres. Methods: A retrospective study was performed …

Background: Several reports indicate a decreased cortisol response to adrenocorticotropic
hormone in preterm infants developing chronic lung disease and in preterm infants with …

Premature births represent 7% to 10% of all births, but account for 85% of all perinatal
complications and death. Survival of extremely premature newborns (28 weeks' gestation) …

OBJECTIVES. Systemic postnatal dexamethasone treatment reduces the risk of chronic lung
disease in preterm infants but also may be associated with increased risk of …

Bronchopulmonary dysplasia (BPD) is a common cause of morbidity and mortality in preterm
neonates and at present its management is unclear. Over the past three decades there has …

AIM To compare the efficacy of hydrocortisone with dopamine for the treatment of
hypotensive, very low birthweight (VLBW) infants. METHODS Forty infants were randomly …

Objective. There is much concern about potential neurodevelopmental impairment after
neonatal corticosteroid treatment for chronic lung disease. Dexamethasone is the …